Drug intelligence / Profile preview

carboxymethylthio-3-(3-chlorophenyl)-1,2,4-oxadiazol

Development stage
Unknown
Modality
Small Molecules
01

Overview

Carboxymethylthio-3-(3-Chlorophenyl)-1,2,4-Oxadiazol is an experimental small molecule compound with the chemical formula C10H7ClN2O3S and a molecular weight of approximately 270.69 g/mol. It is a polycyclic aromatic compound containing a benzene ring linked to a 1,2,4‑oxadiazole ring via a carbon-carbon or carbon-nitrogen bond. The compound has been studied as an experimental agent and is not approved for clinical use in any country. Its primary known biological interaction is with the enzyme cystathionine gamma‑lyase in humans; however its pharmacological action remains unclear and no therapeutic indications have been established[1][5]. There are no reported clinical trials or approved uses for this molecule.

Other names
2-{[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]sulfanyl}acetic acidacetic acid, 2-[[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]thio]-{[3-(3-chlorophényl)-1,2,4-oxadiazol-5-y]sulfanyl}acétique{[3-(3-Chlorphenyl)-1,2,4-Oxadiazol]-5-YL}sulfanylessigsäure2-{[3-(3-Chlorphenyl)-1,2,4-Oxadiazole]-5-YL}sulfanylacetic acid
02

Targets

CTH (Cystathionine gamma-lyase)CGS (Cystathionine gamma-synthase)

Beyond the preview

Go deeper on carboxymethylthio-3-(3-chlorophenyl)-1,2,4-oxadiazol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on carboxymethylthio-3-(3-chlorophenyl)-1,2,4-oxadiazol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call